FindTrial
Sign In

Biomarker study of Neonatal necrotising enterocolitis

Plasma and urine biomarker study of neonatal necrotising enterocolitis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DCD-15005927
Enrollment
Unknown
Registered
2014-08-15
Start date
2015-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

neonatal necrotising enterocolitis

Interventions

Gold Standard:
Index test:

Sponsors

Fudan University Children's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 1 Years

Inclusion criteria

Inclusion criteria: All necrotising enterocolitis newborns whose parents agree to attend this study; control group: same gestation age(+/-7days), same birth weight(+/-100g) and same age(+/-72hours) newborn without NEC and feeding intolerance.

Exclusion criteria

Exclusion criteria: The newborns who have severe congenital anomaly and chromosome defects; the newborns who have necrotising enterocolitis onset 24 hours before admission.

Design outcomes

Primary

MeasureTime frame
I-FABP;protein;—

Contacts

Public ContactChen Chao
chen6010@163.com+86 021-64931186

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026